Cargando…

Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer

Brain tumors are characterized by very high mortality and, despite the continuous research on new pharmacological interventions, little therapeutic progress has been made. One of the main obstacles to improve current treatments is represented by the impermeability of the blood vessels residing withi...

Descripción completa

Detalles Bibliográficos
Autores principales: Parodi, Alessandro, Rudzińska, Magdalena, Deviatkin, Andrei A., Soond, Surinder M., Baldin, Alexey V., Zamyatnin, Andrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572140/
https://www.ncbi.nlm.nih.gov/pubmed/31137689
http://dx.doi.org/10.3390/pharmaceutics11050245
_version_ 1783427570753077248
author Parodi, Alessandro
Rudzińska, Magdalena
Deviatkin, Andrei A.
Soond, Surinder M.
Baldin, Alexey V.
Zamyatnin, Andrey A.
author_facet Parodi, Alessandro
Rudzińska, Magdalena
Deviatkin, Andrei A.
Soond, Surinder M.
Baldin, Alexey V.
Zamyatnin, Andrey A.
author_sort Parodi, Alessandro
collection PubMed
description Brain tumors are characterized by very high mortality and, despite the continuous research on new pharmacological interventions, little therapeutic progress has been made. One of the main obstacles to improve current treatments is represented by the impermeability of the blood vessels residing within nervous tissue as well as of the new vascular net generating from the tumor, commonly referred to as blood-brain barrier (BBB) and blood-brain tumor barrier (BBTB), respectively. In this review, we focused on established and emerging strategies to overcome the blood-brain barrier to increase drug delivery for brain cancer. To date, there are three broad strategies being investigated to cross the brain vascular wall and they are conceived to breach, bypass, and negotiate the access to the nervous tissue. In this paper, we summarized these approaches highlighting their working mechanism and their potential impact on the quality of life of the patients as well as their current status of development.
format Online
Article
Text
id pubmed-6572140
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65721402019-06-18 Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer Parodi, Alessandro Rudzińska, Magdalena Deviatkin, Andrei A. Soond, Surinder M. Baldin, Alexey V. Zamyatnin, Andrey A. Pharmaceutics Review Brain tumors are characterized by very high mortality and, despite the continuous research on new pharmacological interventions, little therapeutic progress has been made. One of the main obstacles to improve current treatments is represented by the impermeability of the blood vessels residing within nervous tissue as well as of the new vascular net generating from the tumor, commonly referred to as blood-brain barrier (BBB) and blood-brain tumor barrier (BBTB), respectively. In this review, we focused on established and emerging strategies to overcome the blood-brain barrier to increase drug delivery for brain cancer. To date, there are three broad strategies being investigated to cross the brain vascular wall and they are conceived to breach, bypass, and negotiate the access to the nervous tissue. In this paper, we summarized these approaches highlighting their working mechanism and their potential impact on the quality of life of the patients as well as their current status of development. MDPI 2019-05-24 /pmc/articles/PMC6572140/ /pubmed/31137689 http://dx.doi.org/10.3390/pharmaceutics11050245 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Parodi, Alessandro
Rudzińska, Magdalena
Deviatkin, Andrei A.
Soond, Surinder M.
Baldin, Alexey V.
Zamyatnin, Andrey A.
Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
title Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
title_full Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
title_fullStr Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
title_full_unstemmed Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
title_short Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
title_sort established and emerging strategies for drug delivery across the blood-brain barrier in brain cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572140/
https://www.ncbi.nlm.nih.gov/pubmed/31137689
http://dx.doi.org/10.3390/pharmaceutics11050245
work_keys_str_mv AT parodialessandro establishedandemergingstrategiesfordrugdeliveryacrossthebloodbrainbarrierinbraincancer
AT rudzinskamagdalena establishedandemergingstrategiesfordrugdeliveryacrossthebloodbrainbarrierinbraincancer
AT deviatkinandreia establishedandemergingstrategiesfordrugdeliveryacrossthebloodbrainbarrierinbraincancer
AT soondsurinderm establishedandemergingstrategiesfordrugdeliveryacrossthebloodbrainbarrierinbraincancer
AT baldinalexeyv establishedandemergingstrategiesfordrugdeliveryacrossthebloodbrainbarrierinbraincancer
AT zamyatninandreya establishedandemergingstrategiesfordrugdeliveryacrossthebloodbrainbarrierinbraincancer